FDA Takes Steps to Advance Genomics Technology, Encourage NGS-based Test Innovation
Two new FDA guidances on next generation sequencing-based tests aim to spur innovation in these tests and streamline their regulatory review. Read More
Two new FDA guidances on next generation sequencing-based tests aim to spur innovation in these tests and streamline their regulatory review. Read More
For Immediate Release Wednesday, April 25, 2018 12:00 p.m. U.S. Eastern Time Media Contact: Nalini Padmanabhan ASHG Director of Communications & Marketing 301.634.7346 press@ashg.org Contest Asked High School Students: How Should People Engage with Direct-to-Consumer Genetic Testing? BETHESDA, MD – As part of its celebration of National DNA Day, the American Society of Human Genetics... Read More
Three years after its publication, how has ASHG's statement on pediatric and adolescent genetic testing affected academic, legal, and public discourse? Read More
Every year, we aim to craft a challenging, thought-provoking, and current question for the DNA Day Essay Contest. Here's how. Read More
In 2018, the U.S. Food and Drug Administration (FDA) invited comments on its intention to exempt a list of class II devices from premarket notification requirements, including tests assessing genetic health risks. ASHG responded to this request for comment by outlining its support for regulation that brings scientifically valid, evidence-based tests to market, and expressing... Read More